BloodScreening Market is expected to reach US$ XX Bn by 2026 at a CAGR of 9.5%during the forecast period.
The report includes the analysis ofimpact of COVID-19 lock-down on the revenue of market leaders, followers, anddisrupters. Since lock down was implemented differently in different regionsand countries, impact of same is also different by regions and segments. Thereport has covered the current short term and long term impact on the market,same will help decision makers to prepare the outline for short term and longterm strategies for companies by region.
A blood screening is a medicalprocess in which a sample of blood is withdrawn from the body to analyze thelevel of substances or cells. It helps to monitor diseases and prevent healthissues and a variety of other conditions such as infections and cancer. Humanimmunodeficiency virus (HIV), blood type, and pregnancy screenings are the mostcommon types of blood screening tests done in the blood screening. Blood donorscreening is the defense mechanism implemented against the spread of infectionprior to the blood donation.
Increase in prevalence ofinfectious diseases, increase in awareness about healthcare, the rise in anumber of blood donations, and a surge in adoption of nucleic acidamplification test (NAT) would create more opportunities for the overall marketgrowth and drive the market positively. However, the threat from substitutetechniques, low donation as compared to requirement and the high cost of kitsor other instruments are the factors that may restrain the market growth ofblood screening.
Blood Screening Market is segmentedby technology, product, and service, end-user and region. Among technology,nucleic acid test (NAT) and enzyme-linked immunosorbent assay (ELISA)accountedfor the XX% share in 2018, nucleic acid test (NAT) are projected to develop atthe XX% growth rate in the coming future due to high sensitivity andspecificity for viral nucleic acid.
Based on products and service,reagents & kits and enzymes and polymerases products are accounted to holdXX% shares in the forecast period of 2018-2026. Reagents& kits product areprojected to develop at the XX% growth rate in the coming future due to therise in blood donations, an increase in the incidence of infectious diseases,and government initiatives.
Among regions, North America isexpected to grow at the XX% CAGR during the forecast period due to the growingadoption of nucleic acid tests (NAT) and increasing participation of variousgovernment associations in blood donations and screening & transfusionactivities. The APAC is expected to grow at the XX% CAGR during the forecastperiod because of the high adoption rate of technologically advanced devicesand presence of improving healthcare infrastructure.
Amongst the key players, Abbottlabs have visible sturdy sales boom within the recent past, primarilyreflecting the effect of acquisitions it made during the last couple of years.Abbott is seeing new development in its medical devices and generic pharmaceuticalsbusiness. It is expected that this trend will continue in the near future aswell. In 2018, Abbott’s Diagnostics business is expected to see a sharp rise inrevenues to around $7 billion mainly due to the influence of the Alereacquisition.
The objective of the report is topresent comprehensive analysis of Blood Screening market including all thestakeholders of the industry. The past and current status of the industry withforecasted market size and trends are presented in the report with analysis ofcomplicated data in simple language. The report covers all the aspects ofindustry with dedicated study of key players that includes market leaders,followers and new entrants by region. PORTER, SVOR, PESTEL analysis with thepotential impact of micro-economic factors by region on the market have beenpresented in the report. External as well as internal factors that are supposedto affect the business positively or negatively have been analyzed, which willgive clear futuristic view of the industry to the decision makers.
The report also helps inunderstanding Blood Screening market dynamics, structure by analyzing themarket segments, and project the Blood Screening market size. Clearrepresentation of competitive analysis of key players by type, price, financialposition, product portfolio, growth strategies, and regional presence in theBlood Screening market make the report investor’s guide.
The Scope of the Report by BloodScreening Market:
• Global Blood Screening Market, byTechnology
• Nucleic Acid Test (NAT)
Real-time Polymerase ChainReaction (PCR)
• Enzyme-linked Immunosorbent Assay(ELISA)
Fluorescence Immunoassay (FIA)
Colorimetric Immunoassay (CI)
Fourth Generation & Above
• Rapid Tests
• Western Blot Assay
• Next-generation Sequencing (NGS)
• Global Blood Screening Market, byProduct & Service
• Reagents & Kits
NAT Reagents & Kits
• Enzymes and Polymerases
• Standards and Controls
• Probes and Primers
• Buffers, Nucleotides, andSolutions
• Labeling and Detection Reagents
ELISA Reagents & Kits
• Sample Diluents and WashSolutions
Other Reagents & Kits
• Software and Services
• Blood Screening Market, by EndUser
• Blood Banks
• Blood Screening Market, By Region
• North America
• Latin America
• Key Players, Blood ScreeningMarket
• Abbott Laboratories
• Roche Diagnostics
• Thermo Fisher Scientific, Inc.
• Bio-Rad Laboratories, Inc.
• Siemens Healthineers
• Ortho Clinical Diagnostics, Inc.
• Becton, Dickinson, and Company
• Beckman Coulter, Inc.
• Becton Dickinson and Company
• Danaher Corporation (BeckmanCoulter)
• F. Hoffmann-La Roche Ltd.
• Enzo Biochem Inc.
• Meridian Bioscience, Inc.
• Immucor, Inc.
• Hologic Inc
For More Information Vist : https://www.maximizemarketresearch.com/market-report/blood-screening-market/13686/
Report Is Submitted By : MaximizeMarket Research Company
Customization of the report:
Maximize Market Research of reportsas per your demand. This report can be personalized to meet your requirements.Get in touch with us and our sales team will guarantee provide you to get areport that suits your necessities.
About Maximize Market Research:
Maximize Market Research providesB2B and B2C research on 20,000 high growth emerging opportunities &technologies as well as threats to the companies across the Healthcare,Pharmaceuticals, Electronics & C
ommunications, Internet of Things,Food and Beverages, Aerospace and Defense and other manufacturing sectors.